semaglutide side effect lawsuit in louisiana Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues kentucky semaglutide digestive blockage law

Drucker and Asa, 1988

These effects may also influence risk of DMO

Key Regulatory Points as of 2026: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical," not intended for human use Not a DEA-scheduled substance, so possession is not illegal (unlike anabolic steroids) Many medical clinics offer BPC-157 treatments despite lack of approval The FDA has expressed safety concerns due to the lack of human clinical trial data and the potential for adverse effects from unregulated manufacturing

The bottom line: With appropriate monitoring (especially in patients with active suicidal ideation or severe eating disorders), GLP-1s appear safe from a psychiatric standpoint